Androo

Bought the midday perk on this OTC multimonth b/o running on Uplisting to NASDAQ PR for o/n. Gapped up slightly due to an Expansion PR and I sold into a small bounce. Great trade!

000

lufc4life

It looked weak as it broke above resistance. Took profits as it pulled back and then bounced. Must try and stick to first green days.

00

-$30 Loss
OGRMFLong Stock
Androo

Bought the midday perk on this OTC multimonth b/o running on Uplisting to NASDAQ PR. Didnt spike as much as I wanted to into the close so I quickly exited half my position and am holding the rest o/n for a gap up. Great trade!

000

BlackWolfTradingCo

Bought first 1000 @ 7.35 about 3 weeks ago on good catalyst. Bought another 1000 this morning @ 7.79 on continuation of breaking 52 wk high. 7.57 avg. Would have liked to stay a while longer but played it safe. Personal schedule in the way.

000

Newsletters:TimAlerts
Broker:Fidelity
$4 Profit
OGRMFLong Stock
TraderCarlos

Tried to pull the First Green Day in this Cannabis OTC. It couldn’t break the 7.4 resistance so I sold before the market closed

000

kylecw2

I bought this stock as they put out a filing that said they got accepted to be uplisted onto NASDAQ. The company hadn't put a PR out so I thought going long the stock before a PR would be ideal. The next morning there was no PR and the price action wasnt taking the stock anywhere so I sold for a small loss.

000

Page
of 26
*Results may not be typical and may vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here.

Never attempt to copy or mirror the trades discussed on this website or in alerts. Attempting to do so may result in substantial financial losses. Alerts are not provided in real-time. For that reason, it is highly unlikely you will be able to buy the stocks at the same entry price, or sell the stocks at the same exit price, to achieve the same or similar profits obtained.